Logo image of COX.PA

NICOX SA (COX.PA) Stock Price, Quote, News and Overview

EPA:COX - Euronext Paris - Matif - FR0013018124 - Common Stock - Currency: EUR

0.579  0 (-0.52%)

COX.PA Quote, Performance and Key Statistics

NICOX SA

EPA:COX (4/27/2023, 7:00:00 PM)

0.579

0 (-0.52%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High2.09
52 Week Low0.55
Market Cap28.92M
Shares49.94M
Float46.22M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO11-02 1999-11-02


COX.PA short term performance overview.The bars show the price performance of COX.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

COX.PA long term performance overview.The bars show the price performance of COX.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of COX.PA is 0.579 EUR. In the past month the price decreased by -8.1%. In the past year, price decreased by -66.14%.

NICOX SA / COX Daily stock chart

COX.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.47 285.10B
AMG.DE AMGEN INC 14.74 139.94B
GIS.DE GILEAD SCIENCES INC 14.99 122.71B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 102.72B
ARGX.BR ARGENX SE 110.77 30.84B
22UA.DE BIONTECH SE-ADR N/A 23.41B
IDP.DE BIOGEN INC 8.27 16.34B
0QF.DE MODERNA INC N/A 11.10B
1MRNA.MI MODERNA INC N/A 11.09B
ABVX.PA ABIVAX SA N/A 3.62B
1VKTX.MI VIKING THERAPEUTICS INC N/A 3.06B
GLPG.AS GALAPAGOS NV N/A 1.79B

About COX.PA

Company Profile

COX logo image Nicox SA is an ophthalmology company. The company is headquartered in Valbonne, Paca. The company is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute conjunctivitis. The firm has also products in the pipeline, such as VESNEO (a drug-candidate for treating glaucoma) and AC-170 (for allergic conjunctivis). The company has a direct commercial presence in Germany, France, the United Kingdom, Italy and Spain, as well as partnerships with local distributors in a number of key international markets.

Company Info

NICOX SA

Drakkar 2 - Batiment D, 2405 route des Dolines, CS 10313 Sophia Antipolis

Valbonne PACA FR

Employees: 32

COX Company Website

Phone: 33497245300.0

NICOX SA / COX.PA FAQ

What is the stock price of NICOX SA today?

The current stock price of COX.PA is 0.579 EUR. The price decreased by -0.52% in the last trading session.


What is the ticker symbol for NICOX SA stock?

The exchange symbol of NICOX SA is COX and it is listed on the Euronext Paris - Matif exchange.


On which exchange is COX.PA stock listed?

COX.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for NICOX SA stock?

8 analysts have analysed COX.PA and the average price target is 2.91 EUR. This implies a price increase of 402.07% is expected in the next year compared to the current price of 0.579. Check the NICOX SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NICOX SA worth?

NICOX SA (COX.PA) has a market capitalization of 28.92M EUR. This makes COX.PA a Nano Cap stock.


How many employees does NICOX SA have?

NICOX SA (COX.PA) currently has 32 employees.


What are the support and resistance levels for NICOX SA (COX.PA) stock?

NICOX SA (COX.PA) has a resistance level at 0.63. Check the full technical report for a detailed analysis of COX.PA support and resistance levels.


Is NICOX SA (COX.PA) expected to grow?

The Revenue of NICOX SA (COX.PA) is expected to grow by 16.23% in the next year. Check the estimates tab for more information on the COX.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NICOX SA (COX.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NICOX SA (COX.PA) stock pay dividends?

COX.PA does not pay a dividend.


What is the Price/Earnings (PE) ratio of NICOX SA (COX.PA)?

NICOX SA (COX.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.61).


COX.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

COX.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to COX.PA. COX.PA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

COX.PA Financial Highlights

Over the last trailing twelve months COX.PA reported a non-GAAP Earnings per Share(EPS) of -0.61. The EPS increased by 47.58% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 0.47
Chartmill High Growth Momentum
EPS Q2Q%74.55%
Sales Q2Q%-68.85%
EPS 1Y (TTM)47.58%
Revenue 1Y (TTM)-54.78%

COX.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to COX.PA. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 35.92% and a revenue growth 16.23% for COX.PA


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts85
Price Target2.91 (402.59%)
EPS Next Y35.92%
Revenue Next Year16.23%